Funding · Company
Aro Biotherapeutics Co
Philadelphia, PABiotech & Pharma
Aro Biotherapeutics Co of Philadelphia, PA has disclosed $114M across 2 Form D offerings filed with the SEC between Dec 16, 2021 and Dec 28, 2022.
$114M
Total disclosed
2
Form D offerings
2017
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$24M
Form D · Dec 28, 2022 ↗
Q4 2022
· target $100M
Filing details
HeadquartersPhiladelphia, PAIndustryBiotech & Pharma (Pharmaceuticals)Incorporated2017SEC CIK0001773305Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. Spot an error? Full methodology →